Medical Affairs Reports
Set fair-market value compensation and protocols for healthcare providers in the Middle East, gathered from top pharmaceutical companies operating in the region.
Use detailed data and best practices to recruit ideal advisory board participants, establish clear protocols to create actionable deliverables and use participant feedback to drive improvements and build relationships with key players.
Examine thought leader management team structures, staffing and budgets. Benchmark pharmaceutical key opinion leader segments for the top three pharma thought leader tiers, five company sizes and 26 therapeutic areas.
Explore the medical affairs organization’s structure and resources as teams take on more medical communication, health economics and thought leader development responsibilities.
Prepare for the Sunshine Act by adapting educational speaker program teams, speaker recruitment tactics and event management.
Allocate MSL time by prioritizing key responsibilities, addressing stakeholder needs and demonstrating value through performance measurement.
Benchmark MSL teams’ structure, budgets and compensation.
Manage medical information call centers and a growing list of other key med info responsibilities.
Demonstrate medical publications' value, boost investment and meet diverse stakeholder needs for clinical and scientific information.
Develop a cohesive IIT strategy, reap study benefits, and streamline proposal review and ongoing oversight.
Improve Phase IV strategy and execution with strong leadership and benchmarks for budgets, staffing, trial timelines and more.
Set a physician fee schedule with fair-market value compensation data for key opinion leaders across multiple specialty areas.
Set fair-market value compensation and fee schedules for European key opinion leaders (KOLs).
Strengthen your diabetes Medical Science Liaison team with hard-to-find data on budgets, staffing, field activities and compensation.
Explore education challenges, measure program effectiveness and improve overall pharmaceutical CME management.